Muhammad Zohaib Khan 2024. FREQUENCY OF END OF TREATMENT RESPONSE IN GENOTYPE 3 CIRRHOTIC PATIENTS TAKING SOFOSBUVIR, RIBAVIRIN AND DACLATASVIR. Journal of Population Therapeutics and Clinical Pharmacology. 31, 9 (Sep. 2024), 4104–4128. DOI:https://doi.org/10.53555/vgped651.